| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...
The best option is to deploy semi-autonomous models where agents recommend actions, but humans validate and approve those actions. As reliability grows over time, organizations will increase their ...
With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are communicating increasing concern about potential product development ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug ...
China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time regulators take to review clinical trials. In a draft policy posted (Chinese ...
SYDNEY--(BUSINESS WIRE)--Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback